BUY CHAPTERS

Global Ophthalmology Treatment Market Insights and Forecast to 2028

Q: How big is the ophthalmology treatment market?

Drugsforophthalmology which are used to treat eye conditions and eye diseases such as glaucoma conjunctivitis and others.Market Analysis and Insights Global Ophthalmology Treatment MarketThe global Ophthalmology Treatment market size is projected to reach US 78130 million by 2028 from US 57570 million in 2021 at a CAGR of 4.4 during 20222028.Fully considering the economic change by this health crisis Gels accounting for of the Ophthalmology Treatment global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

Q: Who are the key players in the ophthalmology treatment market?

Some of the key players are Allergan plc, Aerie Pharmaceuticals, Pfizer Inc, Valeant, Bayer, Genentech Inc, Novartis, Regeneron, Takeda, Santen Pharmaceutical, Novartis AG, Japan, Others.

Code: QYRE-Auto-35V3940

Report

February 2022

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Allergan plc

Aerie Pharmaceuticals

Pfizer Inc

Valeant

Bayer

Genentech Inc

Novartis

Regeneron

Takeda

Santen Pharmaceutical

Novartis AG

Japan

Global Ophthalmology Treatment Market 2028

The global Ophthalmology Treatment market size is projected to reach US$ 78130 million by 2028, from US$ 57570 million in 2021, at a CAGR of 4.4% during 2022-2028.

Drugs for ophthalmology, which are used to treat eye conditions and eye diseases such as glaucoma, conjunctivitis and others.

Fully considering the economic change by this health crisis, Gels accounting for % of the Ophthalmology Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Ophthalmology Treatment market size is valued at US$ million in 2021, while the North America and Europe Ophthalmology Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Ophthalmology Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ophthalmology Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ophthalmology Treatment market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ophthalmology Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ophthalmology Treatment market.

Global Ophthalmology Treatment Scope and Market Size

Ophthalmology Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Ophthalmology Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments

Segment by Application

Hospital
Retail Pharmacy

BY COMPANY

Allergan
Aerie Pharmaceuticals
Pfizer
Valeant
Bayer
Genentech
Novartis
Regeneron
Takeda
Santen Pharmaceutical

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ophthalmology Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Gels

1.2.3 Eye Solutions

1.2.4 Capsules & Tablets

1.2.5 Eye Drops

1.2.6 Ointments

1.3 Market by Application

1.3.1 Global Ophthalmology Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Ophthalmology Treatment Market Perspective (2017-2028)

2.2 Ophthalmology Treatment Growth Trends by Region

2.2.1 Ophthalmology Treatment Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Ophthalmology Treatment Historic Market Size by Region (2017-2022)

2.2.3 Ophthalmology Treatment Forecasted Market Size by Region (2023-2028)

2.3 Ophthalmology Treatment Market Dynamics

2.3.1 Ophthalmology Treatment Industry Trends

2.3.2 Ophthalmology Treatment Market Drivers

2.3.3 Ophthalmology Treatment Market Challenges

2.3.4 Ophthalmology Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ophthalmology Treatment Players by Revenue

3.1.1 Global Top Ophthalmology Treatment Players by Revenue (2017-2022)

3.1.2 Global Ophthalmology Treatment Revenue Market Share by Players (2017-2022)

3.2 Global Ophthalmology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Ophthalmology Treatment Revenue

3.4 Global Ophthalmology Treatment Market Concentration Ratio

3.4.1 Global Ophthalmology Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ophthalmology Treatment Revenue in 2021

3.5 Ophthalmology Treatment Key Players Head office and Area Served

3.6 Key Players Ophthalmology Treatment Product Solution and Service

3.7 Date of Enter into Ophthalmology Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Ophthalmology Treatment Breakdown Data by Type

4.1 Global Ophthalmology Treatment Historic Market Size by Type (2017-2022)

4.2 Global Ophthalmology Treatment Forecasted Market Size by Type (2023-2028)

5 Ophthalmology Treatment Breakdown Data by Application

5.1 Global Ophthalmology Treatment Historic Market Size by Application (2017-2022)

5.2 Global Ophthalmology Treatment Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Ophthalmology Treatment Market Size (2017-2028)

6.2 North America Ophthalmology Treatment Market Size by Type

6.2.1 North America Ophthalmology Treatment Market Size by Type (2017-2022)

6.2.2 North America Ophthalmology Treatment Market Size by Type (2023-2028)

6.2.3 North America Ophthalmology Treatment Market Share by Type (2017-2028)

6.3 North America Ophthalmology Treatment Market Size by Application

6.3.1 North America Ophthalmology Treatment Market Size by Application (2017-2022)

6.3.2 North America Ophthalmology Treatment Market Size by Application (2023-2028)

6.3.3 North America Ophthalmology Treatment Market Share by Application (2017-2028)

6.4 North America Ophthalmology Treatment Market Size by Country

6.4.1 North America Ophthalmology Treatment Market Size by Country (2017-2022)

6.4.2 North America Ophthalmology Treatment Market Size by Country (2023-2028)

6.4.3 the United States

6.4.4 Canada

7 Europe

7.1 Europe Ophthalmology Treatment Market Size (2017-2028)

7.2 Europe Ophthalmology Treatment Market Size by Type

7.2.1 Europe Ophthalmology Treatment Market Size by Type (2017-2022)

7.2.2 Europe Ophthalmology Treatment Market Size by Type (2023-2028)

7.2.3 Europe Ophthalmology Treatment Market Share by Type (2017-2028)

7.3 Europe Ophthalmology Treatment Market Size by Application

7.3.1 Europe Ophthalmology Treatment Market Size by Application (2017-2022)

7.3.2 Europe Ophthalmology Treatment Market Size by Application (2023-2028)

7.3.3 Europe Ophthalmology Treatment Market Share by Application (2017-2028)

7.4 Europe Ophthalmology Treatment Market Size by Country

7.4.1 Europe Ophthalmology Treatment Market Size by Country (2017-2022)

7.4.2 Europe Ophthalmology Treatment Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ophthalmology Treatment Market Size (2017-2028)

8.2 Asia-Pacific Ophthalmology Treatment Market Size by Type

8.2.1 Asia-Pacific Ophthalmology Treatment Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Ophthalmology Treatment Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Ophthalmology Treatment Market Share by Type (2017-2028)

8.3 Asia-Pacific Ophthalmology Treatment Market Size by Application

8.3.1 Asia-Pacific Ophthalmology Treatment Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Ophthalmology Treatment Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Ophthalmology Treatment Market Share by Application (2017-2028)

8.4 Asia-Pacific Ophthalmology Treatment Market Size by Region

8.4.1 Asia-Pacific Ophthalmology Treatment Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Ophthalmology Treatment Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Ophthalmology Treatment Market Size (2017-2028)

9.2 Latin America Ophthalmology Treatment Market Size by Type

9.2.1 Latin America Ophthalmology Treatment Market Size by Type (2017-2022)

9.2.2 Latin America Ophthalmology Treatment Market Size by Type (2023-2028)

9.2.3 Latin America Ophthalmology Treatment Market Share by Type (2017-2028)

9.3 Latin America Ophthalmology Treatment Market Size by Application

9.3.1 Latin America Ophthalmology Treatment Market Size by Application (2017-2022)

9.3.2 Latin America Ophthalmology Treatment Market Size by Application (2023-2028)

9.3.3 Latin America Ophthalmology Treatment Market Share by Application (2017-2028)

9.4 Latin America Ophthalmology Treatment Market Size by Country

9.4.1 Latin America Ophthalmology Treatment Market Size by Country (2017-2022)

9.4.2 Latin America Ophthalmology Treatment Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ophthalmology Treatment Market Size (2017-2028)

10.2 Middle East & Africa Ophthalmology Treatment Market Size by Type

10.2.1 Middle East & Africa Ophthalmology Treatment Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Ophthalmology Treatment Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Ophthalmology Treatment Market Share by Type (2017-2028)

10.3 Middle East & Africa Ophthalmology Treatment Market Size by Application

10.3.1 Middle East & Africa Ophthalmology Treatment Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Ophthalmology Treatment Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Ophthalmology Treatment Market Share by Application (2017-2028)

10.4 Middle East & Africa Ophthalmology Treatment Market Size by Country

10.4.1 Middle East & Africa Ophthalmology Treatment Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Ophthalmology Treatment Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Allergan

11.1.1 Allergan Company Details

11.1.2 Allergan Business Overview

11.1.3 Allergan Ophthalmology Treatment Introduction

11.1.4 Allergan Revenue in Ophthalmology Treatment Business (2017-2022)

11.1.5 Allergan Recent Developments

11.2 Aerie Pharmaceuticals

11.2.1 Aerie Pharmaceuticals Company Details

11.2.2 Aerie Pharmaceuticals Business Overview

11.2.3 Aerie Pharmaceuticals Ophthalmology Treatment Introduction

11.2.4 Aerie Pharmaceuticals Revenue in Ophthalmology Treatment Business (2017-2022)

11.2.5 Aerie Pharmaceuticals Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Ophthalmology Treatment Introduction

11.3.4 Pfizer Revenue in Ophthalmology Treatment Business (2017-2022)

11.3.5 Pfizer Recent Developments

11.4 Valeant

11.4.1 Valeant Company Details

11.4.2 Valeant Business Overview

11.4.3 Valeant Ophthalmology Treatment Introduction

11.4.4 Valeant Revenue in Ophthalmology Treatment Business (2017-2022)

11.4.5 Valeant Recent Developments

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Ophthalmology Treatment Introduction

11.5.4 Bayer Revenue in Ophthalmology Treatment Business (2017-2022)

11.5.5 Bayer Recent Developments

11.6 Genentech

11.6.1 Genentech Company Details

11.6.2 Genentech Business Overview

11.6.3 Genentech Ophthalmology Treatment Introduction

11.6.4 Genentech Revenue in Ophthalmology Treatment Business (2017-2022)

11.6.5 Genentech Recent Developments

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Ophthalmology Treatment Introduction

11.7.4 Novartis Revenue in Ophthalmology Treatment Business (2017-2022)

11.7.5 Novartis Recent Developments

11.8 Regeneron

11.8.1 Regeneron Company Details

11.8.2 Regeneron Business Overview

11.8.3 Regeneron Ophthalmology Treatment Introduction

11.8.4 Regeneron Revenue in Ophthalmology Treatment Business (2017-2022)

11.8.5 Regeneron Recent Developments

11.9 Takeda

11.9.1 Takeda Company Details

11.9.2 Takeda Business Overview

11.9.3 Takeda Ophthalmology Treatment Introduction

11.9.4 Takeda Revenue in Ophthalmology Treatment Business (2017-2022)

11.9.5 Takeda Recent Developments

11.10 Santen Pharmaceutical

11.10.1 Santen Pharmaceutical Company Details

11.10.2 Santen Pharmaceutical Business Overview

11.10.3 Santen Pharmaceutical Ophthalmology Treatment Introduction

11.10.4 Santen Pharmaceutical Revenue in Ophthalmology Treatment Business (2017-2022)

11.10.5 Santen Pharmaceutical Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Allergan plc

Aerie Pharmaceuticals

Pfizer Inc

Valeant

Bayer

Genentech Inc

Novartis

Regeneron

Takeda

Santen Pharmaceutical

Novartis AG

Japan

List of Tables

Table 1. Global Ophthalmology Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Gels

Table 3. Key Players of Eye Solutions

Table 4. Key Players of Capsules & Tablets

Table 5. Key Players of Eye Drops

Table 6. Key Players of Ointments

Table 7. Global Ophthalmology Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 8. Global Ophthalmology Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 9. Global Ophthalmology Treatment Market Size by Region (2017-2022) & (US$ Million)

Table 10. Global Ophthalmology Treatment Market Share by Region (2017-2022)

Table 11. Global Ophthalmology Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 12. Global Ophthalmology Treatment Market Share by Region (2023-2028)

Table 13. Ophthalmology Treatment Market Trends

Table 14. Ophthalmology Treatment Market Drivers

Table 15. Ophthalmology Treatment Market Challenges

Table 16. Ophthalmology Treatment Market Restraints

Table 17. Global Ophthalmology Treatment Revenue by Players (2017-2022) & (US$ Million)

Table 18. Global Ophthalmology Treatment Revenue Share by Players (2017-2022)

Table 19. Global Top Ophthalmology Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Treatment as of 2021)

Table 20. Ranking of Global Top Ophthalmology Treatment Companies by Revenue (US$ Million) in 2021

Table 21. Global 5 Largest Players Market Share by Ophthalmology Treatment Revenue (CR5 and HHI) & (2017-2022)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Ophthalmology Treatment Product Solution and Service

Table 24. Date of Enter into Ophthalmology Treatment Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Ophthalmology Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 27. Global Ophthalmology Treatment Revenue Market Share by Type (2017-2022)

Table 28. Global Ophthalmology Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 29. Global Ophthalmology Treatment Revenue Market Share by Type (2023-2028)

Table 30. Global Ophthalmology Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 31. Global Ophthalmology Treatment Revenue Share by Application (2017-2022)

Table 32. Global Ophthalmology Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 33. Global Ophthalmology Treatment Revenue Share by Application (2023-2028)

Table 34. North America Ophthalmology Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 35. North America Ophthalmology Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 36. North America Ophthalmology Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 37. North America Ophthalmology Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 38. North America Ophthalmology Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 39. North America Ophthalmology Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 40. Europe Ophthalmology Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 41. Europe Ophthalmology Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 42. Europe Ophthalmology Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 43. Europe Ophthalmology Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 44. Europe Ophthalmology Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 45. Europe Ophthalmology Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 46. Asia Pacific Ophthalmology Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 47. Asia Pacific Ophthalmology Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 48. Asia Pacific Ophthalmology Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 49. Asia Pacific Ophthalmology Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 50. Asia Pacific Ophthalmology Treatment Market Size by Region (2017-2022) & (US$ Million)

Table 51. Asia Pacific Ophthalmology Treatment Market Size by Region (2023-2028) & (US$ Million)

Table 52. Latin America Ophthalmology Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 53. Latin America Ophthalmology Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 54. Latin America Ophthalmology Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 55. Latin America Ophthalmology Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 56. Latin America Ophthalmology Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 57. Latin America Ophthalmology Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 58. Middle East and Africa Ophthalmology Treatment Market Size by Type (2017-2022) & (US$ Million)

Table 59. Middle East and Africa Ophthalmology Treatment Market Size by Type (2023-2028) & (US$ Million)

Table 60. Middle East and Africa Ophthalmology Treatment Market Size by Application (2017-2022) & (US$ Million)

Table 61. Middle East and Africa Ophthalmology Treatment Market Size by Application (2023-2028) & (US$ Million)

Table 62. Middle East and Africa Ophthalmology Treatment Market Size by Country (2017-2022) & (US$ Million)

Table 63. Middle East and Africa Ophthalmology Treatment Market Size by Country (2023-2028) & (US$ Million)

Table 64. Allergan Company Details

Table 65. Allergan Business Overview

Table 66. Allergan Ophthalmology Treatment Product

Table 67. Allergan Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 68. Allergan Recent Developments

Table 69. Aerie Pharmaceuticals Company Details

Table 70. Aerie Pharmaceuticals Business Overview

Table 71. Aerie Pharmaceuticals Ophthalmology Treatment Product

Table 72. Aerie Pharmaceuticals Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 73. Aerie Pharmaceuticals Recent Developments

Table 74. Pfizer Company Details

Table 75. Pfizer Business Overview

Table 76. Pfizer Ophthalmology Treatment Product

Table 77. Pfizer Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 78. Pfizer Recent Developments

Table 79. Valeant Company Details

Table 80. Valeant Business Overview

Table 81. Valeant Ophthalmology Treatment Product

Table 82. Valeant Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 83. Valeant Recent Developments

Table 84. Bayer Company Details

Table 85. Bayer Business Overview

Table 86. Bayer Ophthalmology Treatment Product

Table 87. Bayer Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 88. Bayer Recent Developments

Table 89. Genentech Company Details

Table 90. Genentech Business Overview

Table 91. Genentech Ophthalmology Treatment Product

Table 92. Genentech Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 93. Genentech Recent Developments

Table 94. Novartis Company Details

Table 95. Novartis Business Overview

Table 96. Novartis Ophthalmology Treatment Product

Table 97. Novartis Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 98. Novartis Recent Developments

Table 99. Regeneron Company Details

Table 100. Regeneron Business Overview

Table 101. Regeneron Ophthalmology Treatment Product

Table 102. Regeneron Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 103. Regeneron Recent Developments

Table 104. Takeda Company Details

Table 105. Takeda Business Overview

Table 106. Takeda Ophthalmology Treatment Product

Table 107. Takeda Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 108. Takeda Recent Developments

Table 109. Santen Pharmaceutical Company Details

Table 110. Santen Pharmaceutical Business Overview

Table 111. Santen Pharmaceutical Ophthalmology Treatment Product

Table 112. Santen Pharmaceutical Revenue in Ophthalmology Treatment Business (2017-2022) & (US$ Million)

Table 113. Santen Pharmaceutical Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Ophthalmology Treatment Market Share by Type: 2021 VS 2028

Figure 2. Gels Features

Figure 3. Eye Solutions Features

Figure 4. Capsules & Tablets Features

Figure 5. Eye Drops Features

Figure 6. Ointments Features

Figure 7. Global Ophthalmology Treatment Market Share by Application: 2021 VS 2028

Figure 8. Hospital Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Ophthalmology Treatment Report Years Considered

Figure 11. Global Ophthalmology Treatment Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 12. Global Ophthalmology Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Ophthalmology Treatment Market Share by Region: 2021 VS 2028

Figure 14. Global Ophthalmology Treatment Market Share by Players in 2021

Figure 15. Global Top Ophthalmology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Treatment as of 2021)

Figure 16. The Top 10 and 5 Players Market Share by Ophthalmology Treatment Revenue in 2021

Figure 17. North America Ophthalmology Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 18. North America Ophthalmology Treatment Market Size Market Share by Type (2017-2028)

Figure 19. North America Ophthalmology Treatment Market Size Market Share by Application (2017-2028)

Figure 20. North America Ophthalmology Treatment Market Size Share by Country (2017-2028)

Figure 21. United States Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Canada Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Europe Ophthalmology Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 24. Europe Ophthalmology Treatment Market Size Market Share by Type (2017-2028)

Figure 25. Europe Ophthalmology Treatment Market Size Market Share by Application (2017-2028)

Figure 26. Europe Ophthalmology Treatment Market Size Share by Country (2017-2028)

Figure 27. Germany Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. France Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. U.K. Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Italy Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Russia Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Nordic Countries Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Asia-Pacific Ophthalmology Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 34. Asia Pacific Ophthalmology Treatment Market Size Market Share by Type (2017-2028)

Figure 35. Asia Pacific Ophthalmology Treatment Market Size Market Share by Application (2017-2028)

Figure 36. Asia Pacific Ophthalmology Treatment Market Size Share by Region (2017-2028)

Figure 37. China Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Japan Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. South Korea Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Southeast Asia Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. India Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Australia Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 43. Latin America Ophthalmology Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 44. Latin America Ophthalmology Treatment Market Size Market Share by Type (2017-2028)

Figure 45. Latin America Ophthalmology Treatment Market Size Market Share by Application (2017-2028)

Figure 46. Latin America Ophthalmology Treatment Market Size Share by Country (2017-2028)

Figure 47. Mexico Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Brazil Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Middle East & Africa Ophthalmology Treatment Market Size YoY (2017-2028) & (US$ Million)

Figure 50. Middle East and Africa Ophthalmology Treatment Market Size Market Share by Type (2017-2028)

Figure 51. Middle East and Africa Ophthalmology Treatment Market Size Market Share by Application (2017-2028)

Figure 52. Middle East and Africa Ophthalmology Treatment Market Size Share by Country (2017-2028)

Figure 53. Turkey Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Saudi Arabia Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. UAE Ophthalmology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. Allergan Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 57. Aerie Pharmaceuticals Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 58. Pfizer Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 59. Valeant Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 60. Bayer Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 61. Genentech Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 62. Novartis Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 63. Regeneron Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 64. Takeda Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 65. Santen Pharmaceutical Revenue Growth Rate in Ophthalmology Treatment Business (2017-2022)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Ophthalmology Treatment Market Insights and Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-35V3940

Global Ophthalmology Treatment Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

RELATED REPORTS